Assessing the Japet.W+ Lumbar Traction Device in Rehabilitation for Patients With Non-specific Mechanical Low Back Pain
Launched by GRAND HÔPITAL DE CHARLEROI · Dec 1, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the JAPET.W+ Lumbar Traction Device to see if it can help people suffering from low back pain that isn't caused by a specific injury or condition. The trial will include adults aged 18 to 80 who have experienced this type of back pain for more than six weeks. Participants will be divided into two groups: one group will receive treatment using the JAPET.W+, while the other group will not receive this device, allowing researchers to compare the effects.
To qualify for the trial, participants need to have low back pain that is not linked to a specific medical issue, and they must be able to understand the study and agree to participate by signing a form. However, certain individuals won't be eligible, such as those with recent back surgery or specific medical conditions like serious heart or lung problems. If you decide to participate, you can expect to undergo treatment with the JAPET.W+ device, and the trial aims to find out if this device can improve your back pain and overall recovery. The study is not yet recruiting participants, but it could provide valuable insights into new treatment options for low back pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Nonspecific mechanical low back pain for more than 6 weeks,
- • 18 years ≤ Age \< 80 years,
- • Patient affiliated to the health social security system,
- • Patient able to understand the information relating to the study and to sign the informed consent form
- Exclusion Criteria:
- • Specific low back pain (infectious, inflammatory, tumorous, or traumatic origin),
- • Motor neurological deficits (peripheral or central),
- • Extrapyramidal syndrome,
- • Treatment with implanted neurostimulation,
- • Cardiac or circulatory diseases or serious respiratory problems,
- • Previous recent arthrodesis or recent lumbar prosthesis surgery,
- • Surgery for herniated disc (\<3 months),
- • Fracture of the dorsolumbar spine or rib (\<3 months),
- • Skin lesions, contusions and stretching injuries of the trunk,
- • Pregnancy,
- • Individuals not tolerating the JAPET.W+ device during an initial trial,
- • Under guardianship, curatorship or legal protection
About Grand Hôpital De Charleroi
Grand Hôpital de Charleroi is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Charleroi, Belgium, the hospital is committed to excellence in clinical research, collaborating with multidisciplinary teams to evaluate new therapies and interventions across various medical fields. With a focus on ethical standards and patient safety, Grand Hôpital de Charleroi aims to contribute to the global medical community by fostering groundbreaking discoveries and enhancing treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleroi, Hainaut, Belgium
Patients applied
Trial Officials
Serge TROUSSEL, MD
Principal Investigator
Grand Hôpital de Charleroi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported